Skip to content

Pilot Dispensing Evaluation of a Plus Power Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01228591
Enrollment
38
Registered
2010-10-26
Start date
2010-10-31
Completion date
2010-11-30
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperopia

Brief summary

The purpose of this study is to compare the performance of the ACUVUE® ADVANCE® Plus lenses against ACUVUE® ADVANCE® lenses in the plus power parameters.

Interventions

DEVICEAcuvue Advance Plus

Silicone hydrogel contact lens.

DEVICEAcuvue Advance

Silicone hydrogel contact lens

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* The subject must be at least 18 years of age and no more than 45 years of age. * The subject is a current spherical soft contact lens wearer and willing to wear the study lenses on a daily wear basis for the duration of the study (defined as a minimum of 6 hours with a minimum of at least 1 month's wear prior to the study). * The subject's optimal verified spherical equivalent distance correction must be between +1.00 and + 6.00D. * Any cylinder power must be ≤ 0.75D. * The subject must have visual acuity best correctable to 20/25+3 or better for each eye. * The subject must read and sign the Statement of Informed Consent. * The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol.

Exclusion criteria

* Ocular or systemic allergies or disease which might interfere with contact lens wear. * Systemic disease or use of medication which might interfere with contact lens wear. * Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear. * Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear. * Any ocular infection. * Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear. * Pregnancy or lactation. * Diabetes. * Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV). * Habitual contact lens type is toric, bifocal, in monovision contact lens wear, or is worn as extended wear. * Need any near correction.

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity One Week After Lens Wear1 weekVisual acuity was measured using ETDRS visual acuity test. ETDRS stands for Early Treatment Diabetic Retinopathy Study. Binocular and monocular measurements were collected.
Visual Acuity at Time of Initial FitAfter 10-15 minutes of lens wearVisual acuity will be measured using ETDRS visual acuity test. ETDRS stands for Early Treatment Diabetic Retinopathy Study.

Secondary

MeasureTime frameDescription
Contact Lens Comfort Using Contact Lens User Experience (CLUE)1 weekThe subjective comfort questionnaire CLUE, assesses the overall lens comfort. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120.
Subject Reported Vision Using Contact Lens User Experience (CLUE).1 weekOverall vision was assessed by a subjective vision questionnaire. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120.
Contact Lens Comfort at Initial Fit Using Contact Lens User Experience (CLUE)BaselineComfort was assessed using a subjective comfort questionnaire. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. CLUE scores have a range of 0-120.
Subject Reported Vision at Initial Fit Using Contact Lens User Experience (CLUE)BaselineVision at initial fit was assessed using a subjective vision questionnaire. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120.

Countries

United States

Participant flow

Recruitment details

This is a 3 site, 3 visit, randomized, double-masked, bilateral crossover trial comparing Acuvue Advance to Acuvue Advance Plus lenses.

Pre-assignment details

Of the 38 subjects enrolled, 2 were ineligible and not-randomized, 3 discontinued, and 33 completed as cohort.

Participants by arm

ArmCount
All Subjects
Subjects who were randomized and successfully completed the study.
33
Total33

Withdrawals & dropouts

PeriodReasonFG000FG001
BaselineLack of Efficacy12

Baseline characteristics

CharacteristicAll Subjects
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
33 Participants
Age, Continuous29.8 years
STANDARD_DEVIATION 5.66
Region of Enrollment
United States
33 participants
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 330 / 33
serious
Total, serious adverse events
0 / 330 / 33

Outcome results

Primary

Visual Acuity at Time of Initial Fit

Visual acuity will be measured using ETDRS visual acuity test. ETDRS stands for Early Treatment Diabetic Retinopathy Study.

Time frame: After 10-15 minutes of lens wear

Population: Analysis is conducted on those were enrolled and completed the trial.

ArmMeasureGroupValue (MEAN)Dispersion
Acuvue Advance PlusVisual Acuity at Time of Initial FitLow Luminance/High Contrast (Binocular)0.13 LogMARStandard Deviation 0.087
Acuvue Advance PlusVisual Acuity at Time of Initial FitLow Luminance/High Contrast (Monocular)0.16 LogMARStandard Deviation 0.106
Acuvue Advance PlusVisual Acuity at Time of Initial FitHigh Luminance/Low Contrast (Binocular)0.14 LogMARStandard Deviation 0.076
Acuvue Advance PlusVisual Acuity at Time of Initial FitHigh Luminance/Low Contrast (Monocular)0.24 LogMARStandard Deviation 0.123
Acuvue AdvanceVisual Acuity at Time of Initial FitHigh Luminance/Low Contrast (Monocular)0.21 LogMARStandard Deviation 0.111
Acuvue AdvanceVisual Acuity at Time of Initial FitLow Luminance/High Contrast (Binocular)0.11 LogMARStandard Deviation 0.073
Acuvue AdvanceVisual Acuity at Time of Initial FitHigh Luminance/Low Contrast (Binocular)0.13 LogMARStandard Deviation 0.094
Acuvue AdvanceVisual Acuity at Time of Initial FitLow Luminance/High Contrast (Monocular)0.15 LogMARStandard Deviation 0.101
Comparison: For Low Luminance/ High Contrast Grouping (Monocular):~Ho: The test lens (Advance Plus) will be non-inferior to the control lens (Advance).~Ha: The test lens (Advance Plus) will be \<= to the control lens (Advance).95% CI: [0.0041, 0.0282]Mixed Models Analysis
Comparison: For High Luminance/ Low Contrast Grouping (Binocular):~Ho: The test lens (Advance Plus) will be non-inferior from the control lens (Advance).~Ha: The test lens (Advance Plus) will be \<= to the control lens (Advance).95% CI: [0.009, 0.3305]Mixed Models Analysis
Primary

Visual Acuity One Week After Lens Wear

Visual acuity was measured using ETDRS visual acuity test. ETDRS stands for Early Treatment Diabetic Retinopathy Study. Binocular and monocular measurements were collected.

Time frame: 1 week

Population: Subjects analyzed were those who were enrolled, randomized, and completed the study. Both monocular and binocular measurements were taken and included in analysis.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Acuvue Advance PlusVisual Acuity One Week After Lens WearLow Luminance/ High Contrast (Binocular)0.11 LogMARStandard Error 0.082
Acuvue Advance PlusVisual Acuity One Week After Lens WearLow Luminance/ High Contrast (Monocular)0.14 LogMARStandard Error 0.1
Acuvue Advance PlusVisual Acuity One Week After Lens WearHigh Luminance/ Low Contrast (Binocular)0.12 LogMARStandard Error 0.075
Acuvue Advance PlusVisual Acuity One Week After Lens WearHigh Luminance/ Low Contrast (Monocular)0.22 LogMARStandard Error 0.108
Acuvue AdvanceVisual Acuity One Week After Lens WearHigh Luminance/ Low Contrast (Monocular)0.21 LogMARStandard Error 0.097
Acuvue AdvanceVisual Acuity One Week After Lens WearLow Luminance/ High Contrast (Binocular)0.10 LogMARStandard Error 0.063
Acuvue AdvanceVisual Acuity One Week After Lens WearHigh Luminance/ Low Contrast (Binocular)0.13 LogMARStandard Error 0.067
Acuvue AdvanceVisual Acuity One Week After Lens WearLow Luminance/ High Contrast (Monocular)0.14 LogMARStandard Error 0.088
Comparison: For Low Luminance/ High Contrast grouping (Monocular):~Ho: The test lens (Acuvue Advance Plus) will be non-inferior to the control lens (Acuvue Advance).~Ha: The test lens (Acuvue Advance Plus) will be \<= to the control lens (Acuvue Advance).95% CI: [-0.0044, 0.0187]Mixed Models Analysis
Comparison: High Luminance/ Low Contrast grouping (Binocular):~Ho: The test lens (Acuvue Advance Plus) will be non-inferior to the control lens (Acuvue Advance).~Ha: The test lens (Acuvue Advance Plus) will be \<= to the control lens (Acuvue Advance).95% CI: [-0.0086, 0.0146]Mixed Models Analysis
Secondary

Contact Lens Comfort at Initial Fit Using Contact Lens User Experience (CLUE)

Comfort was assessed using a subjective comfort questionnaire. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. CLUE scores have a range of 0-120.

Time frame: Baseline

Population: Analysis was on those who were enrolled and completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Acuvue Advance PlusContact Lens Comfort at Initial Fit Using Contact Lens User Experience (CLUE)65.3 CLUE pointsStandard Error 3.14
Acuvue AdvanceContact Lens Comfort at Initial Fit Using Contact Lens User Experience (CLUE)59.0 CLUE pointsStandard Error 3.19
Secondary

Contact Lens Comfort Using Contact Lens User Experience (CLUE)

The subjective comfort questionnaire CLUE, assesses the overall lens comfort. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120.

Time frame: 1 week

Population: Analysis was on those who were enrolled and completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Acuvue Advance PlusContact Lens Comfort Using Contact Lens User Experience (CLUE)49.2 CLUE pointsStandard Error 3.28
Acuvue AdvanceContact Lens Comfort Using Contact Lens User Experience (CLUE)50.7 CLUE pointsStandard Error 3.26
Secondary

Subject Reported Vision at Initial Fit Using Contact Lens User Experience (CLUE)

Vision at initial fit was assessed using a subjective vision questionnaire. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120.

Time frame: Baseline

Population: Subjects analyzed included only those who were enrolled and completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Acuvue Advance PlusSubject Reported Vision at Initial Fit Using Contact Lens User Experience (CLUE)46.7 CLUE pointsStandard Error 3.9
Acuvue AdvanceSubject Reported Vision at Initial Fit Using Contact Lens User Experience (CLUE)49.6 CLUE pointsStandard Error 3.98
Secondary

Subject Reported Vision Using Contact Lens User Experience (CLUE).

Overall vision was assessed by a subjective vision questionnaire. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120.

Time frame: 1 week

Population: Analysis was on those who were enrolled and completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Acuvue Advance PlusSubject Reported Vision Using Contact Lens User Experience (CLUE).42.5 CLUE pointsStandard Error 2.87
Acuvue AdvanceSubject Reported Vision Using Contact Lens User Experience (CLUE).39.9 CLUE pointsStandard Error 2.86

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026